Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 4 non-open-market transactions below 12 months to the week close of 2026-10-23

Price change vs the latest weekly close (updated to the current quote in your browser when available), split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Nov. 20, 2025 RMD A 1,073 · · 6,002 Direct +21.77% Acquired
Nov. 20, 2024 RMD A 1,083 · · 4,929 Direct +28.16% Acquired
Nov. 16, 2023 RMD A 1,768 · · 3,846 Direct +85.08% Acquired
Nov. 16, 2022 RMD A 1,122 · · 2,078 Direct +117.36% Acquired

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Initial ownership (Form 3) 1 holding

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
Nov. 22, 2021 RMD ResMed Common Stock 956 Direct